Skip to main
VEEV

Veeva Systems (VEEV) Stock Forecast & Price Target

Veeva Systems (VEEV) Analyst Ratings

Based on 21 analyst ratings
Buy
Strong Buy 24%
Buy 48%
Hold 29%
Sell 0%
Strong Sell 0%

Bulls say

Veeva Systems is a dominant player in the life sciences industry, with a large and expanding market opportunity. The company's best-of-breed offerings and strong domain expertise allow it to efficiently and compliantly serve customers ranging from small biotech companies to global pharmaceutical manufacturers. With a track record of solid financial performance and a strong outlook for future growth, Veeva is a compelling investment.

Bears say

Veeva Systems is facing several challenges that could have a negative impact on its financial performance. Despite beating revenue and earnings expectations, the company's reliance on the life sciences industry makes it vulnerable to any downturns or regulatory changes in that sector. Additionally, the expected slowdown in subscription revenue and challenges in its R&D segment could hinder future growth potential. Furthermore, any unexpected hurdles in integrating its recent acquisition of Gentiva could also negatively affect the company's financials. As such, there is a potential for multiple compression in the company's SaaS space, posing risks to its stock value.

Veeva Systems (VEEV) has been analyzed by 21 analysts, with a consensus rating of Buy. 24% of analysts recommend a Strong Buy, 48% recommend Buy, 29% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Veeva Systems and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Veeva Systems (VEEV) Forecast

Analysts have given Veeva Systems (VEEV) a Buy based on their latest research and market trends.

According to 21 analysts, Veeva Systems (VEEV) has a Buy consensus rating as of Jun 3, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $274.29, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $274.29, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Veeva Systems (VEEV)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.